Neurotoxicity Research

, Volume 8, Issue 1–2, pp 135–148 | Cite as

The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia

  • Y. Huang
  • N. Erdmann
  • J. Zhao
  • J. Zheng
Part III Molecular and Cellular Mechanisms of Neuronal Cell Death


HIV-1 Associated Dementia (HAD) develops during progressive HIV-1 infection and is characterized by cognitive impairments, behavioral disorders and potential progressive motor abnormality. Abnormal inflammation within the central nervous system (CNS), activation of macrophage/microglia and involvement of proinflammatory cytokines have been suggested as primary factors in the pathogenesis of HAD. Impairment of neuronal function and neuronal cell death are believed to be the end pathophysiological result of HAD. TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family of cytokines, was suggested to participate in apoptotic cell death during HAD. As a death ligand, TRAIL was originally thought to target only tumor cells. TRAIL is not typically present in CNS; however, emerging data show that TRAIL can be induced by immune stimuli on macrophage and microglia, major disease effector cells during HAD. Upregulated TRAIL may then cause neuronal apoptosis through direct interaction with TRAIL receptors on neurons or through macrophage death-mediated release of neurotoxins. In this review, we summarize the pivotal role of TRAIL in HAD and TRAIL-initiated intracellular death cascades that culminate in neuronal apoptosis as observed in HAD.


HIV-1 associated dementia Apoptosis TRAIL Macrophage Neurons 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adamson DC, B Wildemann, M Sasaki, JD Glass, JC McArthur, VI Christov, TM Dawson and VL Dawson (1996) Immunologic NO synthase, elevation in severe AIDS dementia and Induction by HIV-1 gp41.Science 274, 1917–1926.PubMedCrossRefGoogle Scholar
  2. Almasan A and A Ashkenazi (2003) Apo2L/TRAIL, apoptosis signaling, biology, and potential for cancer therapy.Cytokine Growth Factor Rev. 14, 337–348.PubMedCrossRefGoogle Scholar
  3. Aquaro S, S Panti, MC Caroleo, E Balestra, A Cenci, F Forbici, G Ippolito, A Mastino, R Testi, V Mollace, R Calio and CF Perno (2000) Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes.J. Leukoc. Biol. 68, 429–435.PubMedGoogle Scholar
  4. Ashkenazi A and VM Dixit (1998) Death receptors, signaling and modulation.Science 281, 1305–1308.PubMedCrossRefGoogle Scholar
  5. Bachis A, EO Major and I Mocchetti (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization.J. Neurosci. 23, 5715–5722.PubMedGoogle Scholar
  6. Balachandran S, PC Roberts, T Kipperman, KN Bhalla, RW Compans, DR Archer and GN Barber (2000) Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway.J. Virol. 74, 1513–1523.PubMedCrossRefGoogle Scholar
  7. Batchelor PE, GT Liberatore, JY Wong, MJ Porritt, F Frerichs, GA Donnan and DW Howells (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell linederived neurotrophic factor.J. Neurosci. 19, 1708–1716.PubMedGoogle Scholar
  8. Boatright KM and GS Salvesen (2003) Mechanisms of caspase activation.Curr. Opin. Cell. Biol. 15, 725–731.PubMedCrossRefGoogle Scholar
  9. Boatright KM, M Renatus, FL Scott, S Sperandio, H Shin, IM Pedersen, JE Ricci, WA Edris, DP Sutherlin, DR Green and GS Salvesen (2003) A unified model for apical caspase activation.Mol. Cell 11, 529–541.PubMedCrossRefGoogle Scholar
  10. Bredesen DE (1995) Neural apoptosis. Ann. Neurol. 38, 839–851.PubMedCrossRefGoogle Scholar
  11. Brenneman DE, GL Westbrook, SP Fitzgerald, DL Ennist, KL Elkins, MR Ruff and CB Pert (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.Nature 335, 639–642.PubMedCrossRefGoogle Scholar
  12. Budka H (1986) Multinucleated giant cells in brain, a hallmark of the acquired immune deficiency syndrome (AIDS).Acta Neuropathol. 69, 253–258.PubMedCrossRefGoogle Scholar
  13. Cantarella G, D Uberti, T Carsana, G Lombardo, R Bernardini and M Memo (2003) Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity.Cell Death Differ. 10, 134–141.PubMedCrossRefGoogle Scholar
  14. Carpenter CC, DA Cooper, MA Fischl, JM Gatell, BG Gazzard, SM Hammer, MS Hirsch, DM Jacobsen, DA Katzenstein, JS Montaner, DD Richman, MS Saag, M Schechter, RT Schooley, MA Thompson, S Vella, PG Yeni and PA Volberding (2000) Antiretroviral therapy in adults, updated recommendations of the International AIDS Society-USA Panel.JAMA 283, 381–390.PubMedCrossRefGoogle Scholar
  15. Chang LJ, CH Chen, V Urlacher and TZ Lee (2000) Differential apoptosis effects of primate lentiviral Vpr and Vpx in mammalian cells.J. Biomed. Sci. 7, 322–333.PubMedCrossRefGoogle Scholar
  16. Chaudhary PM, M Eby, A Jasmin, A Bookwalter, J Murray and L Hood (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD- dependent apoptosis and activate the NF-kappaB pathway.Immunity 7, 821–830.PubMedCrossRefGoogle Scholar
  17. Clem RJ (2001) Baculoviruses and apoptosis, the good, the bad, and the ugly.Cell Death Differ. 8, 137–143.PubMedCrossRefGoogle Scholar
  18. Conant K, A Garzino-Demo, A Nath, JC McArthur, W Halliday, C Power, RC Gallo and EO Major (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.Proc. Natl. Acad. Sci. USA 95, 3117–3121.PubMedCrossRefGoogle Scholar
  19. Conti L, P Matarrese, B Varano, MC Gauzzi, A Sato, W Malorni, F Belardelli and S Gessani (2000) Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells.J. Immunol. 165, 3293–3300.PubMedGoogle Scholar
  20. Crocker SJ, P Liston, H Anisman, CJ Lee, PD Smith, N Earl, CS Thompson, DS Park, RG Korneluk and GS Robertson (2003) Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice.Neurobiol. Dis. 12, 150–161.PubMedCrossRefGoogle Scholar
  21. Danial NN and SJ Korsmeyer (2004) Cell death, critical control points.Cell 116, 205–219.PubMedCrossRefGoogle Scholar
  22. Degli-Esposti MA, WC Dougall, PJ Smolak, JY Waugh, CA Smith and RG Goodwin (1997a) The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.Immunity 7, 813–820.CrossRefGoogle Scholar
  23. Degli-Esposti MA, PJ Smolak, H Walczak, J Waugh, CP Huang, RF DuBose, RG Goodwin and CA Smith (1997b) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.J. Exp. Med. 186, 1165–1170.CrossRefGoogle Scholar
  24. Deng Y, Y Lin and X Wu (2002) TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.Genes Dev. 16, 33–45.PubMedCrossRefGoogle Scholar
  25. Di Pietro R and G Zauli (2004) Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.J. Cell. Physiol. 201, 331–340.PubMedCrossRefGoogle Scholar
  26. Diehl GE, HH Yue, K Hsieh, AA Kuang, M Ho, LA Morici, LL Lenz, D Cado, LW Riley and A Winoto (2004) TRAIL-R as a negative regulator of innate immune cell responses.Immunity 21, 877–889.PubMedCrossRefGoogle Scholar
  27. Dore GJ, PK Correll, Y Li, JM Kaldor, DA Cooper and BJ Brew (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.Aids 13, 1249–1253.PubMedCrossRefGoogle Scholar
  28. Dorr J, I Bechmann, S Waiczies, O Aktas, H Walczak, PH Krammer, R Nitsch and F Zipp (2002) Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.J. Neurosci. 22(4), RC209.PubMedGoogle Scholar
  29. Emery JG, P McDonnell, MB Burke, KC Deen, S Lyn, C Silverman, E Dul, ER Appelbaum, C Eichman, R DiPrinzio, RA Dodds, IE James, M Rosenberg, JC Lee and PR Young (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.J. Biol. Chem. 273, 14363–14367.PubMedCrossRefGoogle Scholar
  30. Esser R, W Glienke, H von Briesen, H Rubsamen-Waigmann and R Andreesen (1996) Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 88, 3474–3481.PubMedGoogle Scholar
  31. Ezelle HJ, S Balachandran, F Sicheri, SJ Polyak and GN Barber (2001) Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A.Virology 281, 124–137.PubMedCrossRefGoogle Scholar
  32. Falsig J, M Latta and M Leist (2004) Defined inflammatory states in astrocyte cultures, correlation with susceptibility towards CD95-driven apoptosis.J. Neurochem. 88, 181–193.PubMedGoogle Scholar
  33. Fischer-Smith T, S Croul, AE Sverstiuk, C Capini, D L’Heureux, EG Regulier, MW Richardson, S Amini, S Morgello, K Khalili and J Rappaport (2001) CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.J. Neurovirol. 7, 528–541.PubMedCrossRefGoogle Scholar
  34. Frank S, U Kohler, G Schackert and HK Schackert (1999) Expression of TRAIL and its receptors in human brain tumors.Biochem. Biophys. Res. Commun. 257, 454–459.PubMedCrossRefGoogle Scholar
  35. Gartner S (2000) HIV infection and dementia.Science 287, 602–604.PubMedCrossRefGoogle Scholar
  36. Gelbard HA and LG Epstein (1995) HIV-1 encephalopathy in children.Curr. Opin. Pediatr. 7, 655–662.PubMedGoogle Scholar
  37. Gelbard HA, K Dzenko, D Diloreto, CD Cerro, MD Cerro and LG Epstein (1993) Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA recetor subtypes implications for AIDS neuropathogenesis.Dev. Neurosci. 15, 417–422.PubMedCrossRefGoogle Scholar
  38. Gelbard H, H Nottet, K Dzenko, M Jett, P Genis, R White, L Wang, Y-B Choi, D Zhang, S Lipton, S Swindells, L Epstein and H Gendelman (1994) Platelet-activating factor: a candidate human immunodeficiency virus type-1 infection neurotoxin.J. Virol. 68, 4628–4635.PubMedGoogle Scholar
  39. Genc S, S Kizildag, K Genc, H Ates, N Atabey and S Kizyldag (2003) Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia.Immunol. Lett. 85, 271–274.PubMedCrossRefGoogle Scholar
  40. Gendelman HE (1997) The neuropathogenesis of HIV-1-dementia, In:The Neurology of AIDS, 1st Edition (Gendelman HE, SA Lipton, LG Epstein and S Swindells, Eds.) (Chapman and Hall: New York), pp 1–10.Google Scholar
  41. Gendelman HE and DG Folks (1999) Innate and acquired immunity in neurodegenerative disorders.J. Leuk. Biol. 65, 407–409.Google Scholar
  42. Gendelman HE, Y Persidsky, A Ghorpade, J Limoges, M Stins, M Fiala and R Morrisett (1997) The neuropathogenesis of the AIDS dementia complex.Aids 11, S35-S45.PubMedCrossRefGoogle Scholar
  43. Gibellini D, MC Re, C Ponti, C Maldini, C Celeghini, A Cappellini, M La Placa and G Zauli (2001) HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand.Cell. Immunol. 207, 89–99.PubMedCrossRefGoogle Scholar
  44. Glass JD, H Fedor, SL Wesselingh and JC McArthur (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.Ann. Neurol. 38, 755–762.PubMedCrossRefGoogle Scholar
  45. Gonzalez-Scarano F and J Martin-Garcia (2005) The neuropathogenesis of AIDS.Nat. Rev. Immunol. 5, 69–81.PubMedCrossRefGoogle Scholar
  46. Goyal L (2001) Cell death inhibition: keeping caspases in check.Cell 104, 805–808.PubMedCrossRefGoogle Scholar
  47. Gray F, H Adle-Biassette, F Brion, T Ereau, I le Maner, V Levy and G Corcket (2000) Neuronal apoptosis in human immunodeficiency virus infection.J. Neurovirol. 6 Suppl. 1, S38-S43.PubMedGoogle Scholar
  48. Green DR (2003) The suicide in the thymus, a twisted trail.Nat. Immunol. 4, 207–208.PubMedCrossRefGoogle Scholar
  49. Green DR and JC Reed (1998) Mitochondria and apoptosis.Science 281, 1309–1311.PubMedCrossRefGoogle Scholar
  50. Griffith TS, SR Wiley, MZ Kubin, LM Sedger, CR Maliszewski and NA Fanger (1999) Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.J. Exp. Med. 189, 1343–1354.PubMedCrossRefGoogle Scholar
  51. Gross A, JM McDonnell and SJ Korsmeyer (1999) BCL-2 family members and the mitochondria in apoptosis.Genes Dev. 13, 1899–1911.PubMedCrossRefGoogle Scholar
  52. Guo H, YX Jin, M Ishikawa, YM Huang, PH van der Meide, H Link and BG Xiao (1998) Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand.J. Immunol. 48, 502–508.Google Scholar
  53. Halaas O, R Vik, A Ashkenazi and T Espevik (2000) Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages.Scand. J. Immunol. 51, 244–250.PubMedCrossRefGoogle Scholar
  54. Hesselgesser J, D Taub, P Baskar, M Greenberg, J Hoxie, DL Kolson and R Horuk (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1alpha mediated by the chemokine receptor CXCR4.Curr. Biol. 8, 595–598.PubMedCrossRefGoogle Scholar
  55. Heyes MP, K Saito, A Lackner, CA Wiley, CL Achim and SP Markey (1998) Sources of the neurotoxin quinolinic acid in the brain of HIV-1- infected patients and retrovirus-infected macaques.FASEB J. 12, 881–896.PubMedGoogle Scholar
  56. Huang DC and A Strasser (2000) BH3-Only proteins-essential initiators of apoptotic cell death.Cell 103, 839–842.PubMedCrossRefGoogle Scholar
  57. Huang Y, J Zhao, LA Ryan, A Lopez, H Peng, S Herek and J Zheng (2004) TRAIL induce apoptosis and production of glutamate in HIV-1 infected macrophage: linkage to HIV-1 associated dementia, In:11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA.Google Scholar
  58. Hymowitz SG, HW Christinger, G Fuh, M Ultsch, M O’Connell, RF Kelley, A Ashkenazi and AM de Vos (1999) Triggering cell death, the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.Mol. Cell 4, 563–571.PubMedCrossRefGoogle Scholar
  59. Janssen R, D Cornblath, L Epstein, R Foa, J McArthur, R Price, A Asbury, A Beckett, D Benson, T Bridge, C Levanthal, P Satz, A Saykin, J Sidtis and S Tross (1991) Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type 1 (HIV-1) infection.Neurology 41, 778–785.Google Scholar
  60. Jiang Z, C Piggee, MP Heyes, C Murphy, B Quearry, M Bauer, J Zheng, HE Gendelman and SP Markey (2001) Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.J. Neuroimmunol. 117, 97–107.PubMedCrossRefGoogle Scholar
  61. Jo M, TH Kim, DW Seol, JE Esplen, K Dorko, TR Billiar and SC Strom (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.Nat. Med. 6, 564–567.PubMedCrossRefGoogle Scholar
  62. Jones M, K Olafson, MR Del Bigio, J Peeling and A Nath (1998) Intraventricular injection of human immunodeficiency virus type 1 (HIV- 1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.J. Neuropathol. Exp. Neurol. 57, 563–570.PubMedCrossRefGoogle Scholar
  63. Kaplan MJ, D Ray, RR Mo, RL Yung and BC Richardson (2000) TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.J. Immunol. 164, 2897–2904.PubMedGoogle Scholar
  64. Kaul M, GA Garden and SA Lipton (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia.Nature 410, 988–994.PubMedCrossRefGoogle Scholar
  65. Kayagaki N, N Yamaguchi, M Nakayama, H Eto, K Okumura and H Yagita (1999) Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs.J. Exp. Med. 189, 1451–1460.PubMedCrossRefGoogle Scholar
  66. Kerr S, P Armati and B Brew (1995) Neurocytotoxicity of quinolinic acid in human brain cultures.J. Neurovirol. 1, 375–380.PubMedCrossRefGoogle Scholar
  67. Koenig S, HE Gendelman, JM Orenstein, MCD Canto, GH Pezeshkpour, M Yungbluth, F Janotta, A Aksamit, MA Martin and AS Fauci (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.Science 233, 1089–1093.PubMedCrossRefGoogle Scholar
  68. Krebs FC, H Ross, J McAllister and B Wigdahl (2000) HIV-1-associated central nervous system dysfunction.Adv. Pharmacol. 49, 315–385.PubMedCrossRefGoogle Scholar
  69. La Casse EC, S Baird, RG Korneluk and AE MacKenzie (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer.Oncogene 17, 3247–3259.CrossRefGoogle Scholar
  70. Lama J and CF Ware (2000) Human immunodeficiency virus type 1 Nef mediates sustained membrane expression of tumor necrosis factor and the related cytokine LIGHT on activated T cells.J. Virol. 74, 9396–9402.PubMedCrossRefGoogle Scholar
  71. Lambotte O, Y Taoufik, MGD Goer, C Wallon, C Goujard and JF Delfraissy (2000) Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy.J. AIDS 23, 114–119.Google Scholar
  72. Leaman DW, M Chawla-Sarkar, K Vyas, M Reheman, K Tamai, S Toji and EC Borden (2002) Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.J. Biol. Chem. 277, 28504–28511.PubMedCrossRefGoogle Scholar
  73. LeBlanc HN and A Ashkenazi (2003) Apo2L/TRAIL and its death and decoy receptors.Cell Death Differ. 10, 66–75.PubMedCrossRefGoogle Scholar
  74. Lee J, JS Shin, JY Park, D Kwon, SJ Choi, SJ Kim and IH Choi (2003) p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes.J. Neurosci. Res. 74, 884–890.PubMedCrossRefGoogle Scholar
  75. Li H, H Zhu, CJ Xu and J Yuan (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.Cell 94, 491–501.PubMedCrossRefGoogle Scholar
  76. Li-Weber M, O Laur, K Dern and PH Krammer (2000) T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.Eur. J. Immunol. 30, 661–670.PubMedCrossRefGoogle Scholar
  77. Liston P, WG Fong and RG Korneluk (2003) The inhibitors of apoptosis: there is more to life than Bcl2.Oncogene 22, 8568–8580.PubMedCrossRefGoogle Scholar
  78. Little AR and JP O’Callaghan (2001) Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines?Neurotoxicology 22, 607–618.PubMedCrossRefGoogle Scholar
  79. Liu Y, XP Tang, JC McArthur, J Scott and S Gartner (2000) Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain.J. Neurovirol. 6 Suppl. 1, S70-S81.PubMedGoogle Scholar
  80. Lum JJ, AA Pilon, J Sanchez-Dardon, BN Phenix, JE Kim, J Mihowich, K Jamison, N Hawley-Foss, DH Lynch and AD Badley (2001) induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2L.J. Virol. 75, 11128–11136.PubMedCrossRefGoogle Scholar
  81. Luo X, I Budihardjo, H Zou, C Slaughter and X Wang (1998) Bid, a Bcl2 interacting protein, mediates cytochromec release from mitochondria in response to activation of cell surface death receptors.Cell 94, 481–490.PubMedCrossRefGoogle Scholar
  82. Ma M, JD Geiger and A Nath (1994) Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes.J. Virol. 68, 6824–6828.PubMedGoogle Scholar
  83. Martin-Villalba A, I Herr, I Jeremias, M Hahne, R Brandt, J Vogel, J Schenkel, T Herdegen and KM Debatin (1999) CD 95 Ligand (Fas-L/APO-1L) and tumor necrosis factor related apoptosis inducing ligand mediate ischemia-induced apoptosis in neurons.J. Neurosci. 19, 3809–3817.PubMedGoogle Scholar
  84. Masliah E, CL Achim, N Ge, R DeTeresa, RD Terry and CA Wiley (1992) Spectrum of human immunodeficiency virus-associated neocortical damage.Ann. Neurol. 32, 321–329.PubMedCrossRefGoogle Scholar
  85. Matusevicius D, V Navikas, M Soderstrom, BG Xiao, M Haglund, S Fredrikson and H Link (1996) Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.J. Neuroimmunol. 66, 115–123.PubMedCrossRefGoogle Scholar
  86. Matysiak M, A Jurewicz, D Jaskolski and K Selmaj (2002) TRAIL induces death of human oligodendrocytes isolated from adult brain.Brain 125, 2469–2480.PubMedCrossRefGoogle Scholar
  87. McArthur JC, N Sacktor and O Selnes (1999) Human immunodeficiency virus-associated dementia.Semin. Neurol. 19, 129–150.PubMedCrossRefGoogle Scholar
  88. Meda L, P Baron, E Prat, E Scarpini, G Scarlato, MA Cassatella and F Rossi (1999) Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with betaamyloid[ 25-35].J. Neuroimmunol. 93, 45–52.PubMedCrossRefGoogle Scholar
  89. Milani D, G Zauli, E Rimondi, C Celeghini, S Marmiroli, P Narducci, S Capitani and P Secchiero (2003) Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.J. Neurochem. 86, 126–135.PubMedCrossRefGoogle Scholar
  90. Miller LK (1999) An exegesis of IAPs, salvation and surprises from BIR motifs.Trends Cell Biol. 9, 323–328.PubMedCrossRefGoogle Scholar
  91. Miura Y, Y Koyanagi and H Mizusawa (2003a) TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalopathy.J. Med. Dent. Sci. 50, 17–25.Google Scholar
  92. Miura Y, N Misawa, Y Kawano, H Okada, Y Inagaki, N Yamamoto, M Ito, H Yagita, K Okumura, H Mizusawa and Y Koyanagi (2003b) Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection.Proc. Natl. Acad. Sci. USA 100, 2777–2782.CrossRefGoogle Scholar
  93. Moses AV, FE Bloom, CD Pauza and JA Nelson (1993) HIV infection of human brain capillary endothelial cells occurs via a CD4/ galactosylceramide-independent mechanism.Proc. Natl. Acad. Sci. USA 90, 10474–10478.PubMedCrossRefGoogle Scholar
  94. Nakamura M, J Rieger, M Weller, J Kim, P Kleihues and H Ohgaki (2000) APO2L/TRAIL expression in human brain tumors.Acta Neuropathol. (Berl.) 99, 1–6.CrossRefGoogle Scholar
  95. Nath A and J Geiger (1998) Neurobiological aspects of human immunodeficiency virus infection, neurotoxic mechanisms.Prog. Neurobiol. 54, 19–33.PubMedCrossRefGoogle Scholar
  96. Nath A, V Hartloper, M Furer and KR Fowke (1995) Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission.J. Neuropathol. Exp. Neurol. 54, 320–330.PubMedCrossRefGoogle Scholar
  97. Nath A, J Geiger, M Mattson, D Magnuson, M Jones and J Berger (1998) Role of viral proteins in HIV-1 neuropathogenesis with emphasis on tat.NeuroAIDS 1.Google Scholar
  98. Nath A, K Conant, P Chen, C Scott and EO Major (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon.J. Biol. Chem. 274, 17098–17102.PubMedCrossRefGoogle Scholar
  99. Navia BA (1997) Clinical and biologic features of the AIDS dementia complex.Neuroimaging Clin. N. Am. 7, 581–592.PubMedGoogle Scholar
  100. Navia BA, BD Jordan and RW Price (1986a) The AIDS dementia complex, I. Clinical features. Ann. Neurol. 19, 517–524.CrossRefGoogle Scholar
  101. Navia BA, ES Cho, CK Petito and RW Price (1986b) The AIDS dementia complex, II. Neuropathology.Ann. Neurol. 19, 525–535.CrossRefGoogle Scholar
  102. New DR, M Ma, LG Epstein, A Nath and HA Gelbard (1997) Human immunodeficiency virus type-1 tat protein induces death by apoptosis in primary human neuron cultures.J. Neurovirol. 3, 168–173.PubMedGoogle Scholar
  103. Nishida K, SP Markey, Y Kustova, HC Morse 3rd, P Skolnick, AS Basile and Y Sei (1996) Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated.J. Neurochem. 66, 433–435.PubMedGoogle Scholar
  104. Nitsch R, I Bechmann, RA Deisz, D Haas, TN Lehmann, U Wendling and F Zipp (2000) Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL).Lancet 356, 827–828.PubMedCrossRefGoogle Scholar
  105. Nottet HS, M Jett, CR Flanagan, QH Zhai, Y Persidsky, A Rizzino, EW Bernton, P Genis, T Baldwin, JH Schwartz, CJ LaBenz and HE Gendelman (1995) A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes.J. Immunol. 154, 3567–3581.PubMedGoogle Scholar
  106. Pan G, K O’Rourke, AM Chinnaiyan, R Gentz, R Ebner, J Ni and VM Dixit (1997) The receptor for the cytotoxic ligand TRAIL.Science 276, 111–113.PubMedCrossRefGoogle Scholar
  107. Pan G, J Ni, G-L Yu, Y-F Wei and VM Dixit (1998) TRUNDD a new member of the TRAIL receptor family that antagonizes TRAIL signalling.FEBS Lett. 424, 41–45.PubMedCrossRefGoogle Scholar
  108. Patel CA, M Mukhtar and RJ Pomerantz (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells.J. Virol. 74, 9717–9726.PubMedCrossRefGoogle Scholar
  109. Peng H, Y Huang, Z Duan, D Xu, S Herek, N Erdmann and J Zheng (2005) Cellular IAP1 regulates TRAIL-induced apoptosis in human neural progenitor cells.J. Neurosci. Res. 82, 000–000.CrossRefGoogle Scholar
  110. Perno CF, SM Crowe and RS Kornbluth (1997) A continuing enigma: the role of cells of macrophage lineage in the development of HIV disease.J. Leukoc. Biol. 62, 1–3.PubMedGoogle Scholar
  111. Perry SW, JA Hamilton, LW Tjoelker, G Dbaibo, KA Dzenko, LG Epstein, Y Hannun, JS Whittaker, S Dewhurst and HA Gelbard (1998) Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis.J. Biol. Chem. 273, 17660–17664.PubMedCrossRefGoogle Scholar
  112. Persidsky Y, M Buttini, J Limoges, P Bock and HE Gendelman (1997) An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.J. Neurovirol. 3, 401–416.PubMedCrossRefGoogle Scholar
  113. Pitti RM, SA Marsters, S Ruppert, CJ Donahue, A Moore and A Ashkenazi (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.J. Biol. Chem. 271, 12687–12690.PubMedCrossRefGoogle Scholar
  114. Power C, MJ Gill and RT Johnson (2002) Progress in clinical neurosciences, the neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.Can. J. Neurol. Sci. 29, 19–32.PubMedGoogle Scholar
  115. Pulliam L, R Gascon, M Stubblebine, D McGuire and MS McGrath (1997) Unique monocyte subset in patients with AIDS dementia.Lancet 349, 692–695.PubMedCrossRefGoogle Scholar
  116. Ranki A, M Nyberg, V Ovod, M Haltia, I Elovaara, R Raininko, H Haapasalo and K Krohn (1995) Abundant expression of HIV Nef and Rev proteins in brain astrocytesin vivo is associated with dementia.AIDS 9,1001–1008.PubMedCrossRefGoogle Scholar
  117. Reed JC (2000) Mechanisms of apoptosis.Am. J. Pathol. 157, 1415–1430.PubMedGoogle Scholar
  118. Ricci-Vitiani L, F Pedini, C Mollinari, G Condorelli, D Bonci, A Bez, A Colombo, E Parati, C Peschle and R De Maria (2004) Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death.J. Exp. Med. 200, 1257–1266.PubMedCrossRefGoogle Scholar
  119. Rieger J, H Ohgaki, P Kleihues and M Weller (1999) Human astrocytic brain tumors express AP02L/TRAIL.Acta Neuropathol. (Berl.) 97, 1–4.CrossRefGoogle Scholar
  120. Rubio N, B Martin-Clemente and HL Lipton (2003) High-neurovirulence GDVII virus induces apoptosis in murine astrocytes through tumor necrosis factor (TNF)-receptor and TNF-related apoptosisinducing ligand.Virology 311, 366–375.PubMedCrossRefGoogle Scholar
  121. Ryan LA, J Zheng, M Brester, D Bohac, F Hahn, J Anderson, W Ratanasuwan, HE Gendelman and S Swindells (2001) Plasma levels of soluble cd14 and tumor necrosis factor-alpha type ii receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.J. Infect. Dis. 184, 699–706.PubMedCrossRefGoogle Scholar
  122. Ryan LA, H Peng, DA Erichsen, Y Huang, Y Persidsky, Y Zhou, HE Gendelman and J Zheng (2004) TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1 associated dementia.J. Neuroimmunol. 148, 127–139.PubMedCrossRefGoogle Scholar
  123. Sacktor N, RH Lyles, R Skolasky, C Kleeberger, OA Selnes, EN Miller, JT Becker, B Cohen and JC McArthur (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998.Neurology 56, 257–260.PubMedGoogle Scholar
  124. Sato K, S Hida, H Takayanagi, T Yokochi, N Kayagaki, K Takeda, H Yagita, K Okumura, N Tanaka, T Taniguchi and K Ogasawara (2001) Antiviral responses by natural killer cells through TRAIL induction by interferon-alpha/beta.Eur. J. Immunol. 31, 3138–3146.PubMedCrossRefGoogle Scholar
  125. Schneider P, M Thome, K Burns, JL Bodmer, K Hofmann, T Kataoka, N Holler and J Tschopp (1997) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NFkappaB.Immunity 7, 831–836.PubMedCrossRefGoogle Scholar
  126. Secchiero P, A Gonelli, P Mirandola, E Melloni, L Zamai, C Celeghini, D Milani and G Zauli (2002) Tumor necrosis factorrelated apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspasedependent pathway.Blood 100, 2421–2429.PubMedCrossRefGoogle Scholar
  127. Secchiero P, A Gonelli, E Carnevale, D Milani, A Pandolfi, D Zella and G Zauli (2003) TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.Circulation 107, 2250–2256.PubMedCrossRefGoogle Scholar
  128. Sedger LM, DM Shows, RA Blanton, JJ Peschon, RG Goodwin, D Cosman and SR Wiley (1999) IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.J. Immunol. 163, 920–926.PubMedGoogle Scholar
  129. Seol DW, J Li, MH Seol, SY Park, RV Talanian and TR Billiar (2001) Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAILinduced apoptosis.Cancer Res. 61, 1138–1143.PubMedGoogle Scholar
  130. Sharer LR, ES Cho and LG Epstein (1985) Multinucleated giant cells and HTLV-III in AIDS encephalopathy.Hum. Pathol. 16, 760.PubMedCrossRefGoogle Scholar
  131. Soontornniyomkij V, G Wang, CA Pittman, CA Wiley and CL Achim (1998) Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis.Neuropathol. Appl. Neurobiol. 24, 453–460.PubMedCrossRefGoogle Scholar
  132. Stark GR, IM Kerr, BR Williams, RH Silverman and RD Schreiber (1998) How cells respond to interferons.Annu. Rev. Biochem. 67, 227–264.PubMedCrossRefGoogle Scholar
  133. Strizki JM, AV Albright, H Sheng, M O’Connor, L Perrin and F Gonzalez-Scarano (1996) Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.J. Virol. 70, 7654–7662.PubMedGoogle Scholar
  134. Sylwester A, S Murphy, D Shutt and DR Soll (1997) HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture.J. Immunol. 158, 3996–4007.PubMedGoogle Scholar
  135. Tornatore C, A Nath, K Amemiya and EO Major (1991) Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.J. Virol. 65, 6094–6100.PubMedGoogle Scholar
  136. Uberti D, G Cantarella, F Facchetti, A Cafici, G Grasso, R Bernardini and M Memo (2004) TRAIL is expressed in the brain cells of Alzheimer’s disease patients. Neuroreport 15, 579–581.PubMedCrossRefGoogle Scholar
  137. Walczak H and PH Krammer (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.Exp. Cell Res. 256, 58–66.PubMedCrossRefGoogle Scholar
  138. Walczak H, MA Degli-Esposti, RS Johnson, PJ Smolak, JY Waugh, N Boiani, MS Timour, MJ Gerhart, KA Schooley, CA Smith, RG Goodwin and CT Rauch (1997) TRAIL-R2: a novel apoptosismediating receptor for TRAIL.EMBO J. 16, 5386–5397.PubMedCrossRefGoogle Scholar
  139. Wang X (2001) The expanding role of mitochondria in apoptosis.Genes Dev. 15, 2922–2933.PubMedGoogle Scholar
  140. Wiley CA, RD Schrier, JA Nelson, PW Lampert and MBA Oldstone (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.Proc. Natl. Acad. Sci. USA 83, 7089–7093.PubMedCrossRefGoogle Scholar
  141. Wiley SR, K Schooley, PJ Smolak, WS Din, CP Huang, JK Nicholl, GR Sutherland, TD Smith, C Rauch, CA Smithet al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity 3, 673–682.PubMedCrossRefGoogle Scholar
  142. Wosik K, J Antel, T Kuhlmann, W Bruck, B Massie and J Nalbantoglu (2003) Oligodendrocyte injury in multiple sclerosis, a role for p53.J. Neurochem. 85, 635–644.PubMedGoogle Scholar
  143. Yuan J and BA Yankner (2000) Apoptosis in the nervous system.Nature 407, 802–809.PubMedCrossRefGoogle Scholar
  144. Zhang L, J Yu, BH Park, KW Kinzler and B Vogelstein (2000) Role of BAX in the apoptotic response to anticancer agents.Science 290, 989–992.PubMedCrossRefGoogle Scholar
  145. Zhang M, X Li, X Pang, L Ding, O Wood, K Clouse, I Hewlett and AI Dayton (2001) Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat.J. Biomed. Sci. 8, 290–296.PubMedCrossRefGoogle Scholar
  146. Zhao J, AL Lopez, D Erichsen, S Herek, RL Cotter, NP Curthoys and J Zheng (2004) Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia.J. Neurochem. 88, 169–180.PubMedCrossRefGoogle Scholar
  147. Zhao L, AG Cox, JA Ruzicka, AA Bhat, W Zhang and EW Taylor (2000) Molecular modeling andin vitro activity of an HIV-1- encoded glutathione peroxidase.Proc. Natl. Acad. Sci. USA 97, 6356–6361.PubMedCrossRefGoogle Scholar
  148. Zheng J and HE Gendelman (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes.Curr. Opin. Neurol. 10, 319–325.PubMedCrossRefGoogle Scholar
  149. Zheng J, M Thylin, A Ghorpade, H Xiong, Y Persidsky, R Cotter, D Niemann, M Che, Y Zeng, H Gelbard, R Shepard, J Swartz and H Gendelman (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia.J. Neuroimmunol. 98, 185–200.PubMedCrossRefGoogle Scholar
  150. Zhu Y, HA Gelbard, M Roshal, S Pursell, BD Jamieson and V Planelles (2001) Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.J. Virol. 75, 3791–3801.PubMedCrossRefGoogle Scholar
  151. Zink WE, E Anderson, J Boyle, L Hock, J Rodriguez-Sierra, H Xiong, HE Gendelman and Y Persidsky (2002) Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis.J. Neurosci. 22, 2096–2105.PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.The Laboratory of Neurotoxicology at the Center for Neurovirology & Neurodegenerative DisordersUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.Department of Pharmacology and Experimental NeuroscienceUniversity of Nebraska Medical CenterOmahaUSA
  3. 3.Department of Pathology and MicrobiologyUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations